Manish Acharya

Manish Acharya

Auto-generated profile, based on publicly available information

Manish Acharya

Tribhuvan University Institute of Medicine Maharajgunj Medical Campus

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
6 October 2025 in Clinical Case Reports
Verified
Journal Article
Open access
KKKapil Khanal
Kapil Khanal
SDSunil Dhungana
Sunil Dhungana
BGBindu Gyawali
Bindu Gyawali
RKRishab Khanal
Rishab Khanal
BBBinit Bajracharya
Binit Bajracharya
SSShreya Sinha
Shreya Sinha
Moyamoya disease (MMD) is a rare progressive cerebrovascular disorder characterized by stenosis of the terminal internal carotid arteries with fragile collateral vessel formation. It is common in East Asia but underreported in Nepal. Pediatric cases typically present with ischemic symptoms such as transient ischemic attacks, stroke, or seizures. We report a 7‐year‐old Nepali boy with 11 days of fever followed by recurrent tonic–clonic seizures, progressive right‐sided weakness, and impaired fine motor function. Examination showed right hemiparesis with an upgoing plantar reflex. MRI and MR angiography revealed multiple acute infarcts with supraclinoid internal carotid artery stenosis and extensive collateral vessels, confirming MMD. Cerebrospinal fluid and autoimmune workup were unremarkable. The child was managed conservatively with aspirin and levetiracetam, leading to partial recovery. Surgery was deferred due to financial limitations and initial improvement. This case underscores the importance of considering MMD in pediatric strokes in non‐endemic regions. In resource‐limited settings like Nepal, conservative treatment offers symptomatic relief, but long‐term follow‐up is essential to monitor progression and surgical needs.

11 November 2025 in Clinical Case Reports
Verified
Journal Article
Open access
ASAron Shrestha
Aron Shrestha
NPNavin Poudel
Navin Poudel
KAKshitiz Acharya
Kshitiz Acharya
ACArjun Chaudhary
Arjun Chaudhary
MAManish Acharya
Manish Acharya
BGBibek Ghimire
Bibek Ghimire
Acarbose is usually safe, but overdose can trigger severe, life‐threatening hypoglycemia. In cases of unexplained low blood sugar—particularly in patients with psychiatric illness or access to hypoglycemic drugs—acarbose toxicity should be considered. Rapid intravenous glucose, careful monitoring, and patient education are vital for optimal outcomes.

19 February 2025
Verified
Preprint
Open access
KKKapil Khanal
Kapil Khanal
SDSunil Dhungana
Sunil Dhungana
BGBindu Gyawali
Bindu Gyawali
RKRishab Khanal
Rishab Khanal
NNNishant Neupane
Nishant Neupane
BBBinit Bajracharya
Binit Bajracharya

13 March 2025
Verified
Preprint
Open access
MAManish Acharya
Manish Acharya
KKKapil Khanal
Kapil Khanal
STSagar Thapa
Sagar Thapa
DUDevansh Upadhyay
Devansh Upadhyay
ADArchana Dhakal
Archana Dhakal
RMRamesh Maharjan
Ramesh Maharjan